EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Day

October 29, 2026

Gastric Cancer Registry Leverages AI and Other Tech Advances to Power Growth

As 2026 draws to a close, the Gastric Cancer Registry’s primary investigator, Hanlee Ji, MD, is enthusiastic about the potential for artificial...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 6279
Albany, CA 94706

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

2 days ago

This summer, the Gastric Cancer Foundation and the University of Southern California posted a video on YouTube featuring Foundation board member and “Chef without a Stomach” Hans Rueffert. It was part of a research study called the Spreading Stories Pilot Project, an effort to demystify clinical trials that is being led by USC’s Southern California Clinical and Translational Science Institute. In the video, Rueffert tells the story of his gastric cancer diagnosis and treatment, and he urges patients to learn everything they can about their options, including whether they might benefit from enrolling in clinical trials of emerging treatments. ... See MoreSee Less

USC Partnership Explores Social Media Strategies for Improving Clinical Trial Awareness | Gastric Cancer Foundation

gastriccancer.org

This summer, the Gastric Cancer Foundation and the University of Southern California (USC) posted a video on YouTube featuring Foundation board member and “Chef without a Stomach” Hans Rueffert. I...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 days ago

Join the Gastric Cancer Foundation in advancing research, raising awareness, and moving closer to a future without gastric cancer. Every commitment brings us one step closer. #CommitToACure #gastriccancerfoundation ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

An experimental antibody drug conjugate from our sponsor AstraZeneca reduced the risk of death in gastric cancer patients by 53% in a late-stage clinical trial. The drug, sone-ve, targets the cancer-cell protein claudin 18.2, and though it did not reach its goal for progression-free survival in the study, it did extend overall survival and could be an important addition to the arsenal of treatments, some experts say. #ESMO26 ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

5 days ago

Thank you for tuning into last week's webinar, The Power of Reflection: Processing Emotions While Facing Cancer. You can find the full recording here: ... See MoreSee Less

The Power of Reflection: Processing Emotions While Facing Cancer | GI Cancers Alliance

www.gicancersalliance.org

Join the GI Cancers Alliance, sponsored by Astellas, for a webinar exploring why emotional reflection matters during cancer. This event accompanies the launch of the new Reflections Journal, created i...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

A new analysis from a clinical trial of the CD47 blocker evorpacept from @ALXOncology showed that adding the experimental drug to trastuzumab, ramucirumab and paclitaxel increased the response rate in previously treated HER2-positive gastric cancer patients. Evidence of sustained HER2 positivity and high CD47 levels in tumor biopsies after previous treatments may indicate enriched benefit from the combination, the authors suggested. Via @NatureMedicine ... See MoreSee Less

Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial - Nature Medicine

www.nature.com

In the phase 2 portion of the randomized phase 2/3 ASPEN-06 trial in patients with HER2-positive advanced gastric cancer, which progressed on anti-HER2 treatment, addition of the next-generation CD47 ...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X